Artificial Intelligence

A new alliance brings enterprise-grade cyber resilience to vector databases, helping regulated industries move AI from experiment to production securely.

Get ready for a car that knows you. Cinemo's agentic AI promises hyper-personalized rides, blurring the lines between your vehicle and your digital life.

A new partnership aims to power a tech boom in Southwest Virginia with a massive gas-fired plant, sparking hopes for revival and questions about energy.

A new pharma-tech alliance aims to leverage quantum computing and AI to create safer opioids, but the non-binding deal faces significant hurdles.

Avantor appoints financial heavyweight Simon Dingemans to its board, a strategic move to accelerate its ambitious turnaround amid market pressures.

Leaders from PepsiCo, Unilever, and Kraft Heinz are guiding FourKites' AI roadmap to build more resilient and automated consumer goods supply chains.

Newly public AI firm Fusemachines unveils an ambitious 2026 growth plan, but faces significant financial hurdles and deep investor skepticism.

With a key drill target identified at its Rio Tinto-partnered project in Montana, the junior explorer is poised for a pivotal year in the hunt for copper.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

Exceptional drill results reveal high-grade copper and gold, potentially reshaping the economics of NorthWest's key British Columbia mining asset.

A new partnership aims to build a secure battery supply chain for drones and UAMs, directly responding to US defense restrictions on Chinese tech.

Hisense aims to redefine display tech at CES 2026 with its new RGB MiniLED, focusing on eye comfort and challenging rivals in a crowded smart home market.

The automaker adopts advanced IP management software to protect its innovations in EVs and autonomous driving, signaling a critical industry-wide shift.

Molecular Partners readies for a pivotal presentation at the J.P. Morgan conference, showcasing its next-gen DARPin therapeutics for hard-to-treat cancers.

Completing a key mission 5 months early, Rocket Lab deployed novel DiskSat tech, cementing its role in the U.S. military's agile space strategy.

A top consulting firm is using AI to measure emotional intelligence, claiming it boosts profits. Is this the future of HR or a step into surveillance?

Global agency INVNT appoints its first Chief AI Officer, betting on a unique human-centric leader to navigate the AI revolution in brand storytelling.

With a bold IPO filing, Boumarang plans to leverage hydrogen power, advanced AI, and maritime drones to challenge giants in the booming autonomous systems market.

With a pivotal FDA date set for June 2026, Achieve Life Sciences heads to the J.P. Morgan conference to discuss its promising anti-smoking drug.

A Utah biotech reports promising results for a novel mRNA therapy that makes cancer cells look like measles, setting the stage for crucial animal trials.